Vaccines Production. Challenges & Trends in Vaccine Manufacturing
A Journey through Vaccines’ History, Highlighting Steps And Equipment Involved in Their Complex Aseptic Production Process
Vaccines manufacturing involve a complex aseptic production process that has been challenged in the current pandemic times. Vaccines’ history and their evolution, points to consider when designing a vaccine manufacturing plant, technologies and main equipment used and the whole process qualification, are developed by authors showing the main aspects relevant to achieve a complete aseptic production assuring safety, integrity and efficiency of the process & product.
Rafael Beaus, Global Consultancy Manager at Azbil Telstar holds a Bachelor of Pharmacy from the University of Barcelona (1988), PDG (General Management Program, 2002) from IESE(Barcelona) and Industrial and Pharmacy Technology specialist (2001). He is also an Academic of the Royal Catalan Academy of Pharmacy (2016). After 10 years experience in Production and QA at Alcon Laboratories, joined as GM SVS consultancy, leading its international growth until integration in Telstar more than 15 years ago. He has developed his professional activity as Area Sales Manager and started Telstar subsidiary in Bangladesh as Managing Director, before taking up his current position. He is author of several chapters in many pharmaceutical technology and GMP books, written articles and given lectures worldwide.
Roberto Buzzi has been active in the sales of laboratory equipment at international level for more than 25 years. He has been directly involved in the development of both standard biosafety cabinets and custom made laminar air flow solutions. More recently he has been instrumental in promoting Telstar laboratory freeze drying technology in leading European markets coordinating the activity of sales and product specialists. He is currently Sales Manager at Telstar in Spain, in charge of coordinating the activity of the Research & Medical export sales team located in different Telstar locations worldwide. He holds a degree in Holistic Sciences from the University of Milan.
Toni Lorente, Integrated Pharma Systems Business Development Manager at Telstar, has a degree in engineering from Terrassa School of Industrial Engineering (ESEIT) at Polytechnic University of Catalonia (UPC). He also has an MBA from IESE Business School in Barcelona. Joined Telstar almost 30 years ago, he has especially devoted his activities to pharmaceutical and biotechnology process equipment and services, with a specialized focus on freeze drying technology. For 8 years he was the Lyophilization Technology Unit Manager, where he managed the lyophilization technology sales group, product management and a team of people providing technical and commercial support to global lyophilization projects. In his current position he primarily addresses lyophilization as a main core technology which also includes integration with filling lines and barrier systems.
Tony Rhodes is the Technology Business Development Manager for Barrier Systems based in Telstar UK and holds a HNC in Mechanical & Production Engineering from Leeds Beckett University. Tony has spent the past 25 years working primarily in the containment & aseptic Isolator industry and has held senior roles in Sales and Business Development throughout. He joined Telstar over 9 years ago as Business Development Manager and set about building the Telstar brand and client base in Isolator technology. He then took on the role of Technical Unit Manager and laterally Technology Business Development Manager, thereby assuming responsibility for the complete UK sales team and worldwide responsibility for the sale of aseptic and containment Isolator systems, beging directly involved in securing major projects in aseptic and containment technology for worldwide clients.
Luca Vismara, Technology Business Development Manager of Sterilization Technology at Telstar, has more than 30 years’ experience in sales & product management in manufacturing companies of critical process equipment with high specialization in the field of pharmaceutical sterilization technology. He joined Telstar in 2019 to reinforce Telstar business with special focus in sterilization technology through the development and management of a high-value commercial strategy.